Refractive Laser-Assisted Cataract Surgery vs. Conventional Manual Surgery: Comparing Efficacy and Safety in 3144 Eyes.
To report on outcomes of efficacy and safety in one of the largest series of eyes undergoing either conventional manual cataract surgery (MCS) or refractive femtosecond laser-assisted cataract surgery (ReLACS). Retrospective, consecutive, interventional comparative case series. This study included 3144 consecutive eyes of which 1580 were treated via MCS and 1564 were treated via ReLACS at Uptown Surgical Centre in Vaughan, Canada. Preoperative characteristics, best corrected visual acuity (BCVA), mean absolute spherical error (MAE), rates of intraoperative posterior capsular rupture (PCR), and postoperative complications were evaluated. Across all eyes, ReLACS was superior to MCS for reducing surgical time (MCS: 7.7±0.1 min vs. ReLACS: 6.8±0.1 min, p<0.001), being less associated with postoperative cystoid macular edema (OR=0.36, 95% CI: 0.14-0.91, p=0.031), and for reducing MAE (MCS: 0.60±0.02 D vs. ReLACS: 0.54±0.02 D, p=0.02). There were no differences in rates of PCR (p=0.918), overall postoperative complications (p=0.088), or final BCVA (p=0.881). When analyzing a subgroup of more difficult cases (n=833), ReLACS was superior to MCS for: (1) being more likely to yield an improvement of more than 0.1 LogMAR BCVA (OR=1.80, 95% CI: 1.15-2.74, p=0.01), (2) reducing MAE (MCS: 0.73±0.3 D vs. ReLACS: 0.60±0.27 D, p=0.04), and (3) being more likely to yield a MAE within 0.5 D (OR=1.61, 95% CI: 1.11-2.33, p=0.012). Across all eyes, our results support that ReLACS and MCS yield similar outcomes. However, our results show trends for a more pronounced benefit of ReLACS compared to MCS when treating more difficult eyes.